• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃博拉数据库:用于药物再利用的扎伊尔埃博拉病毒-人类蛋白质相互作用数据库。

Ebolabase: Zaire ebolavirus-human protein interaction database for drug-repurposing.

机构信息

Centre for Bioinformatics, Pondicherry University, Puducherry-605014, India.

Department of Computer Science, Pondicherry University, Puducherry-605014, India.

出版信息

Int J Biol Macromol. 2021 Jul 1;182:1384-1391. doi: 10.1016/j.ijbiomac.2021.04.184. Epub 2021 May 17.

DOI:10.1016/j.ijbiomac.2021.04.184
PMID:34015403
Abstract

Ebola Virus (EBOV) is one of the deadliest pathogenic virus which causes hemorrhagic fever. Though many Ebola-human interaction studies and databases are already reported, the unavailability of an adequate model and lack of publically accessible resources requires a comprehensive study to curate the Ebola-Human-Drug interactions. In total, 270 human proteins interacted with EBOV are collected from published experimental evidence. Then the protein-protein interaction networks are generated as EBOV-human and EBOV-Human-Drugs interaction. These results can help the researcher to find the effective repurposed drug for EBOV treatment. Further, the illustration of gene enrichment and pathway analysis would provide knowledge and insight of EBOV-human interaction describes the importance of the study. Investigating the networks may help to identify a suitable human-based drug target for ebola research community. The inclusion of an emerging concept, a human-based drug targeted therapy plays a very significant role in drug repurposing which reduces the time and effort is the highlight of the current research. An integrated database namely, Ebolabase has been developed and linked with other repositories such as Epitopes, Structures, Literature, Genomics and Proteomics. All generated networks are made to be viewed in a customized manner and the required data can be downloaded freely. The Ebolabase is available at http://ebola.bicpu.edu.in.

摘要

埃博拉病毒(EBOV)是一种致命的病原体病毒,可引起出血热。虽然已经有许多关于埃博拉病毒与人类相互作用的研究和数据库报告,但由于缺乏足够的模型和公开可用的资源,需要进行全面的研究来整理埃博拉病毒与人类药物的相互作用。总共从已发表的实验证据中收集了 270 种与 EBOV 相互作用的人类蛋白。然后生成蛋白质-蛋白质相互作用网络,即 EBOV-人类和 EBOV-人类药物相互作用。这些结果可以帮助研究人员找到用于 EBOV 治疗的有效再利用药物。此外,基因富集和途径分析的说明提供了 EBOV 与人类相互作用的知识和见解,描述了该研究的重要性。研究网络可能有助于确定针对埃博拉病毒研究社区的合适的基于人类的药物靶标。纳入一个新兴概念,即基于人类的药物靶向治疗,在药物再利用中起着非常重要的作用,它可以减少时间和精力,这是当前研究的重点。已经开发了一个名为 Ebolabase 的综合数据库,并与其他存储库(如表位、结构、文献、基因组学和蛋白质组学)链接。所有生成的网络都可以以定制的方式查看,并可以免费下载所需的数据。Ebolabase 可在 http://ebola.bicpu.edu.in 访问。

相似文献

1
Ebolabase: Zaire ebolavirus-human protein interaction database for drug-repurposing.埃博拉数据库:用于药物再利用的扎伊尔埃博拉病毒-人类蛋白质相互作用数据库。
Int J Biol Macromol. 2021 Jul 1;182:1384-1391. doi: 10.1016/j.ijbiomac.2021.04.184. Epub 2021 May 17.
2
Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection.夏枯草提取物对埃博拉病毒糖蛋白(GP)介导的病毒进入和感染的抑制作用的表征
Antiviral Res. 2016 Mar;127:20-31. doi: 10.1016/j.antiviral.2016.01.001. Epub 2016 Jan 9.
3
Targeting Ebola virus replication through pharmaceutical intervention.通过药物干预靶向埃博拉病毒复制。
Expert Opin Investig Drugs. 2021 Mar;30(3):201-226. doi: 10.1080/13543784.2021.1881061.
4
Integrated Computational Approach for Virtual Hit Identification against Ebola Viral Proteins VP35 and VP40.针对埃博拉病毒蛋白VP35和VP40进行虚拟命中识别的综合计算方法。
Int J Mol Sci. 2016 Oct 26;17(11):1748. doi: 10.3390/ijms17111748.
5
High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system.采用埃博拉病毒转录和复制型病毒样颗粒系统进行高通量药物筛选。
Antiviral Res. 2018 Oct;158:226-237. doi: 10.1016/j.antiviral.2018.08.013. Epub 2018 Aug 24.
6
Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses.阿比多尔和其他抑制拉沙病毒和埃博拉病毒的低分子量药物。
J Virol. 2019 Apr 3;93(8). doi: 10.1128/JVI.02185-18. Print 2019 Apr 15.
7
Combinatorial screening of a panel of FDA-approved drugs identifies several candidates with anti-Ebola activities.组合筛选一组经 FDA 批准的药物,鉴定出具有抗埃博拉病毒活性的几种候选药物。
Biochem Biophys Res Commun. 2020 Feb 19;522(4):862-868. doi: 10.1016/j.bbrc.2019.11.065. Epub 2019 Dec 2.
8
Novel Small Molecule Entry Inhibitors of Ebola Virus.新型埃博拉病毒小分子进入抑制剂
J Infect Dis. 2015 Oct 1;212 Suppl 2(Suppl 2):S425-34. doi: 10.1093/infdis/jiv223. Epub 2015 Jul 22.
9
Repurposing Quinacrine against Ebola Virus Infection .抗埃博拉病毒感染的奎纳克林再利用。
Antimicrob Agents Chemother. 2019 Aug 23;63(9). doi: 10.1128/AAC.01142-19. Print 2019 Sep.
10
Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.基于痘病毒的埃博拉病毒表达 GP 和 VP40 蛋白疫苗候选物的免疫原性和疗效的差异。
J Virol. 2018 May 14;92(11). doi: 10.1128/JVI.00363-18. Print 2018 Jun 1.

引用本文的文献

1
Open MoA: revealing the mechanism of action (MoA) based on network topology and hierarchy.开放 MoA:基于网络拓扑和层次结构揭示作用机制 (MoA)。
Bioinformatics. 2023 Nov 1;39(11). doi: 10.1093/bioinformatics/btad666.
2
Artificial Intelligence, Machine Learning, and Big Data for Ebola Virus Drug Discovery.用于埃博拉病毒药物研发的人工智能、机器学习和大数据
Pharmaceuticals (Basel). 2023 Feb 21;16(3):332. doi: 10.3390/ph16030332.
3
Databases, Knowledgebases, and Software Tools for Virus Informatics.病毒信息学数据库、知识库和软件工具。
Adv Exp Med Biol. 2022;1368:1-19. doi: 10.1007/978-981-16-8969-7_1.